260 related articles for article (PubMed ID: 16337192)
1. Amelioration of diabetic peripheral neuropathy by implantation of hematopoietic mononuclear cells in streptozotocin-induced diabetic rats.
Hasegawa T; Kosaki A; Shimizu K; Matsubara H; Mori Y; Masaki H; Toyoda N; Inoue-Shibata M; Nishikawa M; Iwasaka T
Exp Neurol; 2006 Jun; 199(2):274-80. PubMed ID: 16337192
[TBL] [Abstract][Full Text] [Related]
2. Sonic hedgehog induces arteriogenesis in diabetic vasa nervorum and restores function in diabetic neuropathy.
Kusano KF; Allendoerfer KL; Munger W; Pola R; Bosch-Marce M; Kirchmair R; Yoon YS; Curry C; Silver M; Kearney M; Asahara T; Losordo DW
Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2102-7. PubMed ID: 15358602
[TBL] [Abstract][Full Text] [Related]
3. Ameliorating human diabetic neuropathy: lessons from implanting hematopoietic mononuclear cells.
Malik RA; Veves A; Tesfaye S
Exp Neurol; 2006 Sep; 201(1):7-14. PubMed ID: 16808913
[No Abstract] [Full Text] [Related]
4. Aminoguanidine--effects on endoneurial vasoactive nitric oxide and on motor nerve conduction velocity in control and streptozotocin-diabetic rats.
Dewhurst M; Omawari N; Tomlinson DR
Br J Pharmacol; 1997 Feb; 120(4):593-8. PubMed ID: 9051296
[TBL] [Abstract][Full Text] [Related]
5. Effects of trolox on nerve dysfunction, thermal hyperalgesia and oxidative stress in experimental diabetic neuropathy.
Sharma SS; Sayyed SG
Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1022-8. PubMed ID: 17042909
[TBL] [Abstract][Full Text] [Related]
6. Effects of U83836E on nerve functions, hyperalgesia and oxidative stress in experimental diabetic neuropathy.
Sayyed SG; Kumar A; Sharma SS
Life Sci; 2006 Jul; 79(8):777-83. PubMed ID: 16581090
[TBL] [Abstract][Full Text] [Related]
7. Effects of eugenol on nerve and vascular dysfunction in streptozotocin-diabetic rats.
Nangle MR; Gibson TM; Cotter MA; Cameron NE
Planta Med; 2006 May; 72(6):494-500. PubMed ID: 16773532
[TBL] [Abstract][Full Text] [Related]
8. Nerve conduction velocity and evoked potential latencies in streptozotocin-diabetic rats: effects of treatment with an angiotensin converting enzyme inhibitor.
Manschot SM; Gispen WH; Kappelle LJ; Biessels GJ
Diabetes Metab Res Rev; 2003; 19(6):469-77. PubMed ID: 14648806
[TBL] [Abstract][Full Text] [Related]
9. Tanshinone IIA improves impaired nerve functions in experimental diabetic rats.
Liu Y; Wang L; Li X; Lv C; Feng D; Luo Z
Biochem Biophys Res Commun; 2010 Aug; 399(1):49-54. PubMed ID: 20637731
[TBL] [Abstract][Full Text] [Related]
10. [The therapeutic efficacy for limb ischemia by transplantation of mobilized peripheral blood cells before and after CD34+ cell depletion].
Zhou B; Li S; Gu DS; Wu KH; Liu PX; Han ZC
Zhonghua Xue Ye Xue Za Zhi; 2007 Mar; 28(3):194-8. PubMed ID: 17649714
[TBL] [Abstract][Full Text] [Related]
11. Depletion of taurine in experimental diabetic neuropathy: implications for nerve metabolic, vascular, and functional deficits.
Pop-Busui R; Sullivan KA; Van Huysen C; Bayer L; Cao X; Towns R; Stevens MJ
Exp Neurol; 2001 Apr; 168(2):259-72. PubMed ID: 11259114
[TBL] [Abstract][Full Text] [Related]
12. Diabetic neuropathy: electrophysiological and morphological study of peripheral nerve degeneration and regeneration in transgenic mice that express IFNbeta in beta cells.
Serafín A; Molín J; Márquez M; Blasco E; Vidal E; Foradada L; Añor S; Rabanal RM; Fondevila D; Bosch F; Pumarola M
Muscle Nerve; 2010 May; 41(5):630-41. PubMed ID: 19918773
[TBL] [Abstract][Full Text] [Related]
13. Effects of adenosine and adenosine A2A receptor agonist on motor nerve conduction velocity and nerve blood flow in experimental diabetic neuropathy.
Kumar S; Arun KH; Kaul CL; Sharma SS
Neurol Res; 2005 Jan; 27(1):60-6. PubMed ID: 15829161
[TBL] [Abstract][Full Text] [Related]
14. Effects of insulin and dietary myoinositol on impaired peripheral motor nerve conduction velocity in acute streptozotocin diabetes.
Greene DA; De Jesus PV; Winegrad AI
J Clin Invest; 1975 Jun; 55(6):1326-36. PubMed ID: 124320
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of 4-amino1,8-napthalimide, a poly (ADP-ribose) polymerase inhibitor in experimental diabetic neuropathy.
Sharma SS; Kumar A; Kaundal RK
Life Sci; 2008 Mar; 82(11-12):570-6. PubMed ID: 18262571
[TBL] [Abstract][Full Text] [Related]
16. Treatment with the xanthine oxidase inhibitor, allopurinol, improves nerve and vascular function in diabetic rats.
Inkster ME; Cotter MA; Cameron NE
Eur J Pharmacol; 2007 Apr; 561(1-3):63-71. PubMed ID: 17291486
[TBL] [Abstract][Full Text] [Related]
17. Effects of resveratrol on nerve functions, oxidative stress and DNA fragmentation in experimental diabetic neuropathy.
Kumar A; Kaundal RK; Iyer S; Sharma SS
Life Sci; 2007 Mar; 80(13):1236-44. PubMed ID: 17289084
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of neovascularization with mobilized blood cells transplantaion: supply of angioblasts and angiogenic cytokines.
Zhou B; Liu PX; Lan HF; Fang ZH; Han ZB; Ren H; Poon MC; Han ZC
J Cell Biochem; 2007 Sep; 102(1):183-95. PubMed ID: 17390342
[TBL] [Abstract][Full Text] [Related]
19. Preventive and curative effect of edaravone on nerve functions and oxidative stress in experimental diabetic neuropathy.
Saini AK; Kumar H S A; Sharma SS
Eur J Pharmacol; 2007 Jul; 568(1-3):164-72. PubMed ID: 17521626
[TBL] [Abstract][Full Text] [Related]
20. The neurocytokine, interleukin-6, corrects nerve dysfunction in experimental diabetes.
Cameron NE; Cotter MA
Exp Neurol; 2007 Sep; 207(1):23-9. PubMed ID: 17560573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
